ARCHIVES

In Brief: House, Senate Pass Rescision Bills; NCI Compromise Figure Probably About $10 Million Cut For FY 1981

This article is from The Cancer Letter archive.

Vol. 07 No. 22 | May 29, 1981

Download PDF Visit The Full Archive

Related Articles

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

October 3, 2008

New Research Projects Proposed For Immunology

September 30, 1977

Obama Picks Hamburg for FDA Commissioner

March 20, 2009

CTEP Starts New Effort to Bring Minorities Into Clinical Trials

March 2, 1990

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

January 27, 2006

NCI To Offer Compromise On Including “Chop-Like Elements” In CCOP, Agrees Consortia “Appropriate”

May 14, 1982